Autologous hematopoietic stem cell transplantation is the standard treatment option for multiple myeloma and relapsed non-Hodgkin’s lymphoma patients. 2 Chemo-mobilization success depends on the patient’s age, apheresis timing, chemotherapy and immunomodulatory regimens as well as chemotherapy-related adverse events .